A pivotal study testing Sensydia's noninvasive device, which may help diagnose pulmonary hypertension, enrolled its first ...

Inhibikase (IKT) pivots to IkT-001Pro for PAH amid competition like Merck’s sotatercept. Backed by $97.5M, results will ...

A scientific statement regarding disparities in current pulmonary embolism management and outcomes has been published by the AHA.

United Therapeutics’ UTHR first-quarter 2025 earnings of $6.63 per share beat the Zacks Consensus Estimate of $6.29. The ...

Researchers have developed a novel rat model that closely replicates the pathological features and physiological changes ...

Cereno Scientific reported a successful meeting with the FDA on the design of a future clinical trial for its PAH therapy ...

Researchers have developed a novel rat model that closely replicates the pathological features and physiological changes ...

Tyler, Texas-based Christus Mother Frances Hospital had the lowest readmission ratio for coronary artery bypass graft surgery between July 1, 2020, and June 30, 2023, according to CMS data published ...

Medicaid beneficiaries face higher rates of pulmonary hypertension, with significant economic burdens and racial disparities ...

In 2021, a greater number of global pulmonary arterial hypertension cases occurred in females vs. males, and disease ...

Patients with COPD and established cardiovascular disease have more MACEs and seek less preventive cardiac care than patients with CVD alone.